Stay updated with breaking news from Joycem Lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study comparing this weight program against usual care for high risk patients shows higher use of evidence-based treatments and more weight lost
Dispensing of GLP-1 receptor agonists increased nearly 600% among adolescents and young adults in the United States from 2020 to 2023 and was particularly significant among girls and young women, a new study showed.According to Joyce M. Lee, MD, MPH, a professor of pediatrics and communicable diseases at the University of Michigan School of Public Health, and colleagues, interest in GLP-1
For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023.
Females accounted for most of the prescription fills
Public interest in weight loss drugs like Wegovy and Ozempic is surging, but national data on dispensing patterns in the United States is surprisingly scarce.